Renaissance Technologies LLC Holding in Amgen INC (AMGN) Decreased by $111.20 Million as Valuation Declined

July 16, 2018 - By Billy Entrekin

Amgen Inc. (NASDAQ:AMGN) LogoInvestors sentiment decreased to 0.88 in 2018 Q1. Its down 0.34, from 1.22 in 2017Q4. It dived, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Centurylink Invest Mgmt holds 0.91% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 14,864 shares. Check Ca stated it has 3,080 shares. Norinchukin Bank The stated it has 0.29% in Amgen Inc. (NASDAQ:AMGN). Aviance Cap Ltd Liability Corporation invested in 28,248 shares. Northpointe Capital Ltd Liability Com reported 19,164 shares. Moreover, Main Street Limited Com has 1.77% invested in Amgen Inc. (NASDAQ:AMGN). Aspen Investment reported 7,155 shares stake. Epoch Inv Partners Inc owns 110,184 shares or 0.07% of their US portfolio. Aperio Gp Llc accumulated 447,953 shares or 0.38% of the stock. Lmr Partners Limited Liability Partnership owns 0.1% invested in Amgen Inc. (NASDAQ:AMGN) for 5,451 shares. Gulf Interest Bancshares (Uk) Limited has 0.47% invested in Amgen Inc. (NASDAQ:AMGN). Silvercrest Asset Mgmt Group Inc Ltd Liability Co has invested 0.46% in Amgen Inc. (NASDAQ:AMGN). Nuveen Asset Limited Co invested in 0.41% or 369,993 shares. Moreover, First Western Mngmt has 2.44% invested in Amgen Inc. (NASDAQ:AMGN) for 3,023 shares. Clean Yield Gp holds 20,916 shares.

Since February 14, 2018, it had 0 buys, and 5 sales for $1.36 million activity.

Jim Simons decreased its stake in Amgen Inc (AMGN) by 14.28% based on its latest 2018Q1 regulatory filing with the SEC. Renaissance Technologies Llc sold 654,145 shares as the company’s stock declined 5.44% with the market. The hedge fund run by Jim Simons held 3.93M shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $669.19 million, down from 4.58M at the end of the previous reported quarter. Renaissance Technologies Llc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $128.70 billion market cap company. The stock decreased 0.72% or $1.41 during the last trading session, reaching $194.5. About 866,056 shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since July 16, 2017 and is uptrending. It has outperformed by 2.11% the S&P500.

Renaissance Technologies Llc, which manages about $63.99 billion and $91.44B US Long portfolio, upped its stake in Pan American Silver Corp (NASDAQ:PAAS) by 541,800 shares to 4.37M shares, valued at $70.65 million in 2018Q1, according to the filing. It also increased its holding in Johnson Outdoors Inc (NASDAQ:JOUT) by 55,100 shares in the quarter, for a total of 353,600 shares, and has risen its stake in Ssr Mng Inc.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on July, 26 after the close. They expect $3.52 earnings per share, up 7.65 % or $0.25 from last year’s $3.27 per share. AMGN’s profit will be $2.33B for 13.81 P/E if the $3.52 EPS becomes a reality. After $3.47 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 1.44 % EPS growth.

More news for Amgen Inc. (NASDAQ:AMGN) were recently published by: Seekingalpha.com, which released: “Amgen resubmits US marketing application for osteoporosis med Evenity” on July 13, 2018. Fool.com‘s article titled: “Better Buy: Biogen Inc. vs. Amgen” and published on July 15, 2018 is yet another important article.

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Among 12 analysts covering Amgen Inc (NASDAQ:AMGN), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. Amgen Inc had 16 analyst reports since January 18, 2018 according to SRatingsIntel. The rating was maintained by PiperJaffray on Friday, February 2 with “Overweight”. The rating was maintained by Morgan Stanley on Friday, July 13 with “Overweight”. The rating was maintained by Cowen & Co with “Buy” on Thursday, February 1. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Argus Research on Tuesday, January 23. The stock of Amgen Inc. (NASDAQ:AMGN) has “Overweight” rating given on Friday, February 2 by Morgan Stanley. The stock has “Hold” rating by Atlantic Securities on Monday, February 5. Morgan Stanley maintained it with “Overweight” rating and $200 target in Wednesday, April 25 report. On Monday, January 22 the stock rating was maintained by RBC Capital Markets with “Hold”. On Friday, February 2 the stock rating was maintained by BMO Capital Markets with “Market Perform”. The firm earned “Buy” rating on Thursday, February 1 by Piper Jaffray.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.